Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other Non-Current Liabilities (2021 - 2025)

Rockwell Medical filings provide 10 years of Other Non-Current Liabilities readings, the most recent being $2.9 million for Q1 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 16.0% to $2.9 million in Q1 2025 year-over-year; TTM through Mar 2025 was $2.9 million, a 16.0% increase, with the full-year FY2024 number at $1.0 million, down 60.0% from a year prior.
  • Other Non-Current Liabilities hit $2.9 million in Q1 2025 for Rockwell Medical, up from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.9 million in Q1 2025 to a low of $14000.0 in Q4 2021.
  • Median Other Non-Current Liabilities over the past 5 years was $14000.0 (2021), compared with a mean of $947285.7.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 17757.14% in 2023 and later plummeted 60.0% in 2024.
  • Rockwell Medical's Other Non-Current Liabilities stood at $14000.0 in 2021, then changed by 0.0% to $14000.0 in 2022, then soared by 17757.14% to $2.5 million in 2023, then plummeted by 60.0% to $1.0 million in 2024, then skyrocketed by 190.0% to $2.9 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $2.9 million (Q1 2025), $1.0 million (Q4 2024), and $1.8 million (Q3 2024) per Business Quant data.